Pfizer/BioNTech submit initial data on Covid-19 vaccine for people ages 5 to 11 to FDA, but aren’t seeking EUA yet
Both BioNTech and Pfizer said Tuesday that they have acquiesced Covid-19 vaccine data on children ages 5 to 11 to the FDA (Food and Drug Administration) for primary review, but till now there are not yet looking for emergency use approval. Companies said that a formal submission to demand EUA for the vaccine is probable … Read More